HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mark Bardsley Selected Research

Highly Active Antiretroviral Therapy (HAART)

10/2011Evaluation of the United States public health service guidelines for discontinuation of anticytomegalovirus therapy after immune recovery in patients with cytomegalovirus retinitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mark Bardsley Research Topics

Disease

2Acquired Immunodeficiency Syndrome (AIDS)
11/2016 - 10/2011
1Multiple Myeloma
03/2023
1HIV Infections (HIV Infection)
11/2016
1Cytomegalovirus Retinitis
10/2011
1Retinitis
10/2011

Drug/Important Bio-Agent (IBA)

1bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
03/2023
1Broadly Neutralizing AntibodiesIBA
11/2016
1Antiviral Agents (Antivirals)IBA
11/2016

Therapy/Procedure

1Aftercare (After-Treatment)
03/2023
1Immunotherapy
03/2023
1Therapeutics
10/2011
1Highly Active Antiretroviral Therapy (HAART)
10/2011